跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,450 条关于
“Solstice Oncology”
全部
10,450
临床试验
1,866
药物
143
机构
256
资讯
8,185
9天前
Solstice Oncology launches with $225M Series A to advance next-generation CTLA-4 antibody porustobart in neoadjuvant colon cancer
上个月
Harbour BioMed Reports Seventh Consecutive Profitable Half-Year, Driven by Strategic Collaborations and AI-Enabled Pipeline Advances
去年
Vir Biotechnology's SOLSTICE Trial of Soto-mutated Cancer Therapy Shows Promise
去年
Vir Biotechnology's Tobevibart and Elebsiran Combination Shows Promise in Hepatitis Delta Treatment
去年
Vir Biotechnology's SOLSTICE Trial Shows Promise in Hepatitis Delta Virus Treatment
11个月前
Vir Biotechnology to Present 48-Week SOLSTICE Trial Results for Hepatitis Delta Combination Therapy at AASLD 2025
4个月前
Vir Biotechnology to Present 96-Week Data from Phase 2 SOLSTICE Trial for Chronic Hepatitis Delta at EASL Congress 2026
去年
Vir Biotechnology Advances Hepatitis Programs and Oncology Pipeline with Sanofi Deal
去年
Vir Biotechnology Advances Hepatitis and Oncology Programs, Announces Q3 2024 Results
去年
Vir Biotechnology Bolsters Pipeline with Sanofi Deal and Reports Q3 2024 Results
第 1 页,共 819 页
上一页
下一页